JP2019522044A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019522044A5 JP2019522044A5 JP2019515772A JP2019515772A JP2019522044A5 JP 2019522044 A5 JP2019522044 A5 JP 2019522044A5 JP 2019515772 A JP2019515772 A JP 2019515772A JP 2019515772 A JP2019515772 A JP 2019515772A JP 2019522044 A5 JP2019522044 A5 JP 2019522044A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- composition
- fgf2
- use according
- fluid flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021207229A JP2022031368A (ja) | 2016-06-01 | 2021-12-21 | 中枢神経系におけるリンパ管を調節するための方法及び組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662344164P | 2016-06-01 | 2016-06-01 | |
| US62/344,164 | 2016-06-01 | ||
| PCT/US2017/035285 WO2017210343A1 (en) | 2016-06-01 | 2017-05-31 | Methods and compositions for modulating lymphatic vessels in the central nervous system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021207229A Division JP2022031368A (ja) | 2016-06-01 | 2021-12-21 | 中枢神経系におけるリンパ管を調節するための方法及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019522044A JP2019522044A (ja) | 2019-08-08 |
| JP2019522044A5 true JP2019522044A5 (https=) | 2020-07-09 |
Family
ID=60477853
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019515772A Pending JP2019522044A (ja) | 2016-06-01 | 2017-05-31 | 中枢神経系におけるリンパ管を調節するための方法及び組成物 |
| JP2021207229A Pending JP2022031368A (ja) | 2016-06-01 | 2021-12-21 | 中枢神経系におけるリンパ管を調節するための方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021207229A Pending JP2022031368A (ja) | 2016-06-01 | 2021-12-21 | 中枢神経系におけるリンパ管を調節するための方法及び組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11944665B2 (https=) |
| EP (1) | EP3463575B1 (https=) |
| JP (2) | JP2019522044A (https=) |
| AU (1) | AU2017273629B2 (https=) |
| CA (1) | CA3025366A1 (https=) |
| WO (1) | WO2017210343A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017210343A1 (en) | 2016-06-01 | 2017-12-07 | The University Of Virginia Patent Foundation | Methods and compositions for modulating lymphatic vessels in the central nervous system |
| JOP20190248A1 (ar) | 2017-04-21 | 2019-10-20 | Amgen Inc | بروتينات ربط مولد ضد trem2 واستخداماته |
| US12352767B2 (en) | 2018-07-16 | 2025-07-08 | University Of Virginia Patent Foundation | Method of treating cognitive decline associated with neurological diseases based on a decrease in FLT4 expression or activity |
| CN113226283A (zh) * | 2018-10-04 | 2021-08-06 | 罗切斯特大学 | 通过操纵血浆重量摩尔渗透压浓度改善淋巴递送 |
| WO2020102627A1 (en) | 2018-11-16 | 2020-05-22 | Yale University | Manipulation of meningeal lymphatic vasculature for brain and cns tumor therapy |
| WO2021071830A1 (en) | 2019-10-07 | 2021-04-15 | University Of Virginia Patent Foundation | Modulating lymphatic vessels in neurological disease |
| US20230067811A1 (en) | 2020-01-24 | 2023-03-02 | University Of Virginia Patent Foundation | Modulating lymphatic vessels in neurological disease |
| CN114949182B (zh) * | 2022-04-07 | 2025-07-01 | 上海大学 | 一种淋巴管生成诱导剂的用途 |
| US20240207362A1 (en) * | 2022-10-25 | 2024-06-27 | Institute For Basic Science (Ibs) | Extracranial Methods For Facilitating Cerebrospinal Fluid Drainage |
| JP2026510233A (ja) * | 2023-02-16 | 2026-04-02 | ユニバーシティー オブ ロチェスター | グリンパ－リンパ流出の改善 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1132098B1 (en) * | 1999-09-21 | 2010-05-26 | AnGes MG, Inc. | Gene therapy for cerebrovascular disorders |
| US20040214766A1 (en) * | 2001-10-01 | 2004-10-28 | Kari Alitalo | VEGF-C or VEGF-D materials and methods for treatment of neuropathologies |
| US20080057028A1 (en) | 2002-10-02 | 2008-03-06 | Institute Nationale De La Sante Et De La Recherche Medicale (Inserm) | Vegf-C or Vegf-D Materials and Methods for Stimulation of Neural Stem cells |
| US9415090B2 (en) * | 2011-06-01 | 2016-08-16 | Universität Heidelberg | VEGF-D/VEGFR2/3-mediated regulation of dendrites |
| US8852936B2 (en) * | 2012-09-21 | 2014-10-07 | Laurantis Pharma Oy | Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery |
| WO2017190074A1 (en) | 2016-04-28 | 2017-11-02 | The University Of Chicago | Lymphangiogenesis for therapeutic immunomodulation |
| WO2017210343A1 (en) | 2016-06-01 | 2017-12-07 | The University Of Virginia Patent Foundation | Methods and compositions for modulating lymphatic vessels in the central nervous system |
| WO2020102627A1 (en) | 2018-11-16 | 2020-05-22 | Yale University | Manipulation of meningeal lymphatic vasculature for brain and cns tumor therapy |
-
2017
- 2017-05-31 WO PCT/US2017/035285 patent/WO2017210343A1/en not_active Ceased
- 2017-05-31 EP EP17807427.4A patent/EP3463575B1/en active Active
- 2017-05-31 JP JP2019515772A patent/JP2019522044A/ja active Pending
- 2017-05-31 CA CA3025366A patent/CA3025366A1/en active Pending
- 2017-05-31 AU AU2017273629A patent/AU2017273629B2/en active Active
- 2017-05-31 US US16/306,483 patent/US11944665B2/en active Active
-
2021
- 2021-12-21 JP JP2021207229A patent/JP2022031368A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019522044A5 (https=) | ||
| Hall et al. | In vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings | |
| Andica et al. | MR biomarkers of degenerative brain disorders derived from diffusion imaging | |
| Pieperhoff et al. | Regional changes of brain structure during progression of idiopathic Parkinson's disease–a longitudinal study using deformation based morphometry | |
| Villemagne | Amyloid imaging: past, present and future perspectives | |
| Lazarov et al. | Neurogenesis and Alzheimer's disease: at the crossroads | |
| Nakagawa et al. | Involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia | |
| MX2014004516A (es) | Micro-arns en trastornos neurodegenerativos. | |
| Wei et al. | White matter abnormalities in patients with Parkinson's disease: a meta-analysis of diffusion tensor imaging using tract-based spatial statistics | |
| Oeckl et al. | Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: current status and future perspectives | |
| Doorn et al. | Hippocampal proliferation is increased in presymptomatic Parkinson’s disease and due to microglia | |
| Bărbulescu et al. | Neuroinflammation in systemic lupus erythematosus-a review | |
| Wang et al. | Association of longitudinal cognitive decline with diffusion MRI in gray matter, amyloid, and tau deposition | |
| Madeira et al. | Glia-mediated retinal neuroinflammation as a biomarker in Alzheimer's disease | |
| Avants et al. | Amyloid beta–Positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity | |
| Del Bigio et al. | Neuropathology of human hydrocephalus | |
| Macijauskienė et al. | Dementia with Lewy bodies: the principles of diagnostics, treatment, and management | |
| Oggioni et al. | The glymphatic system: a potential key player in bacterial meningitis | |
| Bašić et al. | Apolipoprotein E and matrix remodeling–a link to neurodegeneration in Alzheimer’s disease | |
| Breza et al. | Diffuse glioma manifesting as normal pressure hydrocephalus: A potential pitfall in diagnosis-a case report | |
| Wood | Tau is linked to cognitive decline in Huntington disease | |
| Olsson | Evaluation of amyloid precursor protein and beta-amyloid as biomarkers for Alzheimer's disease. | |
| Apostolova | Structural neuroimaging in degenerative dementias | |
| FU et al. | Clinical and imaging features of precheron artery infarction | |
| PINTO et al. | Normal pressure hydrocephalus: Neuroimaging as a tool for differential diagnosis and outcome predictor |